/

VRAX

Virax Biolabs Group LimitedClosed

1.74−0.11 −6.05%USD

NasdaqCM · as of Oct 13, 16:00 ET · 15m delayAfter hours 1.75 +0.68%

Open

1.81

Prev close

1.85

Day range

1.721.86

52-week range

1.7221.75

Volume

40.27K0.07×

Mkt cap

2.34M

P/E ttm

—

Fwd P/E

-0.29

EPS ttm

-12.64

Div yield

0.00%

Earnings

—

From 52w high

−92.01%

Price Chart

Yahoo Finance · delayed

VRAXOct 13, 2026O 1.80H 1.86L 1.72C 1.74−0.11 (−6.05%)Vol 39.70K

SMA 502.60
SMA 2004.41

1Y change −89.32% since Oct 13, 2025 close539 bars loadedTimes in America/New_YorkDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

VRAX Virax Biolabs Group Limited · Last Guard Finance

DES

Key Statistics

Yahoo Finance

Performance

1 week: −14.38%
1 month: −34.91%
3 months: −53.53%
6 months: −53.03%
Year to date: −79.91%
1 year: −89.32%

Valuation & ownership

Market cap: 2.34M
Enterprise value: −5.34M
P/E (ttm): —
Forward P/E: -0.29
PEG ratio: —
Price / book: 0.13
Price / sales (ttm): 188.18
EV / EBITDA: 0.88
EPS (ttm): -12.64
EPS (forward): -6.00
Beta (5y monthly): 1.39
Dividend yield: 0.00%
Payout ratio: —
Shares outstanding: 1.34M
Float: 529.04K
Short % of float: 0.50%
Short ratio (days): 0.19
Held by insiders: 1.58%
Held by institutions: 1.99%
Avg volume (3m): 615.44K
50-day average: 2.62
200-day average: 4.45
52-week change: −89.32%
S&P 500 52-week: +17.03%

Technicals (daily)

RSI (14): 30.5
vs 50-day SMA: −33.06%
vs 200-day SMA: −60.59%
50 / 200-day trend: ▼ 50 below 200
MACD vs signal: ▼ below
ATR (14) % of price: 15.76%
Realised vol (20d, ann.): 92.3%
From 52-week high: −92.01%
From 52-week low: +1.05%

ANR

Analyst Consensus

No analyst coverage for this instrument.

Financial Snapshot

Full statements →trailing twelve months

Revenue (ttm): 12.42K
Revenue growth (yoy): +684.90%
Earnings growth (yoy): —
Gross margin: 61.90%
Operating margin: -35264.92%
Profit margin: 0.00%

DES

About Virax Biolabs Group Limited

Yahoo Finance profile

Virax Biolabs Group Limited, a biotechnology company, focuses on immune response detection, T cell immune profiling, and the development of in vitro diagnostic technologies for viral and immune-mediated diseases in the United Kingdom, the United States, and China. The company offers ViraxImmune, a T cell-based immune profiling and diagnostic platform for post-acute infection syndromes, including long COVID, myalgic encephalomyelitis / chronic fatigue syndrome, and post-treatment Lyme disease. It also provides ImmuneSelect, a research-use-only portfolio of peptide pool ELISpot plates and related immune reagents. In addition, the company is involved in research and development activities and the provision of procurement, warehousing, product development, and staffing management services. It serves research organizations, academic institutions, contract research organizations, biopharmaceutical companies, independent laboratories, and distributors. The company was formerly known as Virax Biolabs (Cayman) Limited and changed its name to Virax Biolabs Group Limited in September 2021. Virax Biolabs Group Limited was founded in 2013 and is headquartered in Lanarkshire, United Kingdom.

Sector: Healthcare
Industry: Biotechnology
Employees: 26
Headquarters: Lanarkshire, United Kingdom
Website: viraxbiolabs.com
Officers: Mr. James Foster Chairman, CEO & Principal Accounting Officer
Ms. Lily Fu Head of Supply Chain

SEAS

Seasonality · VRAX

2022–2026 · monthly returns

Strongest month Aug +51.07%Weakest month Dec −22.66%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	-18.2	-19.4	-3.5	-39.1	41.0	-37.8	-10.9	7.6	-22.6	-20.4			−79.9%
2025	-24.9	-1.2	-31.7	-14.0	-1.7	-17.8	2.3	-25.2	0.3	-7.6	-28.3	-14.1	−84.6%
2024	-43.8	17.3	-25.5	-12.1	87.3	-1.7	7.3	274.3	-58.4	6.7	-4.8	14.2	+54.1%
2023	3.8	-10.2	2.1	-39.9	-6.2	-0.5	1.8	-9.8	-9.2	-24.6	-4.9	-37.3	−80.0%
2022								-35.0	-10.3	-52.1	3.6	-53.4	−86.5%

VRAX

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

VRAX

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

Financial Snapshot

About Virax Biolabs Group Limited

Seasonality · VRAX

Insider Activity · VRAX

Congress Trades · VRAX

Investors Holding VRAX

Investors Holding VRAX

Congress Trades · VRAX

Seasonality · VRAX

Insider Activity · VRAX

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

Financial Snapshot

About Virax Biolabs Group Limited

Earnings & Dividends

News